Methyl-β-cyclodextrin suppresses the monocyte-endothelial adhesion triggered by lipopolysaccharide (LPS) or oxidized low-density lipoprotein (oxLDL)

References

• Ao MY, Chen Y. 2017. Effects of MβCD on lipoxygenase-induced LDL oxidation. Chem Pharm Bull. 65(2):200–203.
   PubMed Web of Science ®Google Scholar
• Ao MY, Gan CY, Shao WX, Zhou X, Chen Y. 2016a. Effects of cyclodextrins on the structure of LDL and its susceptibility to copper-induced oxidation. Eur J Pharm Sci. 91:183–189.
   PubMed Web of Science ®Google Scholar
• Ao MY, Wang K, Zhou X, Chen G, Zhou Y, Wei B, Shao WX, Huang J, Liao HH, Wang ZX, et al. 2019. Exogenous GM3 ganglioside inhibits atherosclerosis via multiple steps: a potential atheroprotective drug. Pharmacol Res. 148:104445.
   PubMed Web of Science ®Google Scholar
• Ao MY, Wu L, Zhou X, Chen Y. 2016b. Methyl-β-cyclodextrin impairs the monocyte-adhering ability of endothelial cells by down-regulating adhesion molecules and caveolae and reorganizing the actin cytoskeleton. Biol Pharm Bull. 39(6):1029–1034.
   PubMed Web of Science ®Google Scholar
• Ashrafzadeh P, Parmryd I. 2015. Methods applicable to membrane nanodomain studies? Essays Biochem. 57:57–68.
   PubMed Web of Science ®Google Scholar
• Carneiro SB, Duarte FIC, Heimfarth L, Quintans JDS, Quintans LJ, da Veiga VF, de Lima AAN. 2019. Cyclodextrin-drug inclusion complexes: in vivo and in vitro approaches. IJMS. 20(3):642.
   Google Scholar
• Chen Y, Qin J, Cai JY, Chen ZW. 2009. Cold induces micro- and nano-scale reorganization of lipid raft markers at mounds of T-cell membrane fluctuations. PLOS One. 4(4):e5386.
   PubMed Web of Science ®Google Scholar
• Cominacini L, Garbin U, Pasini AF, Davoli A, Campagnola M, Contessi GB, Pastorino AM, Lo Cascio V. 1997a. Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Radic Biol Med. 22(1–2):117–127.
   PubMed Web of Science ®Google Scholar
• Cominacini L, Garbin U, Fratta Pasini A, Paulon T, Davoli A, Campagnola M, Marchi E, Pastorino AM, Gaviraghi G, Lo Cascio V. 1997b. Lacidipine inhibits the activation of the transcription factor NF-kappa B and the expression of adhesion molecules induced by pro-oxidant signals on endothelial cells. J Hypertens. 15:1633–1640.
   PubMed Web of Science ®Google Scholar
• Deng HF, Wang S, Li L, Zhou Q, Guo WB, Wang XL, Liu MD, Liu K, Xiao XZ. 2018. Puerarin prevents vascular endothelial injury through suppression of NF-κB activation in LPS-challenged human umbilical vein endothelial cells. Biomed Pharmacother. 104:261–267.
   PubMed Web of Science ®Google Scholar
• Duchene D, Bochot A. 2016. Thirty years with cyclodextrins. Int J Pharm. 514(1):58–72.
   PubMedGoogle Scholar
• Elamin KM, Yamashita Y, Higashi T, Motoyama K, Arima H. 2018. Supramolecular complex of methyl-β-cyclodextrin with adamantane-grafted hyaluronic acid as a novel antitumor agent. Chem Pharm Bull (Tokyo)). 66(3):277–285.
   PubMed Web of Science ®Google Scholar
• Fu YH, Hu XY, Cao YG, Zhang ZC, Zhang NS. 2015. Saikosaponin a inhibits lipopolysaccharide-oxidative stress and inflammation in human umbilical vein endothelial cells via preventing TLR4 translocation into lipid rafts. Free Radic Biol Med. 89:777–785.
   PubMed Web of Science ®Google Scholar
• Gotoh K, Kariya R, Alam MM, Matsuda K, Hattori S, Maeda Y, Motoyama K, Kojima A, Arima H, Okada S. 2014. The antitumor effects of methyl-β-cyclodextrin against primary effusion lymphoma via the depletion of cholesterol from lipid rafts. Biochem Biophys Res Commun. 455(3–4):285–289.
   PubMed Web of Science ®Google Scholar
• Grosse PY, Bressolle F, Pinguet F. 1998a. Antiproliferative effect of methyl-beta-cyclodextrin in vitro and in human tumour xenografted athymic nude mice. Br J Cancer. 78(9):1165–1169.
   PubMed Web of Science ®Google Scholar
• Grosse PY, Bressolle F, Vago P, Simony-Lafontaine J, Radal M, Pinguet F. 1998b. Tumor cell membrane as a potential target for methyl-beta-cyclodextrin. Anticancer Res. 18(1A):379–384.
   PubMed Web of Science ®Google Scholar
• Huang CS, Lin AH, Yang TC, Liu KL, Chen HW, Lii CK. 2015. Shikonin inhibits oxidized LDL-induced monocyte adhesion by suppressing NFκB activation via up-regulation of PI3K/Akt/Nrf2-dependent antioxidation in EA.hy926 endothelial cells. Biochem Pharmacol. 93(3):352–361.
   PubMed Web of Science ®Google Scholar
• Kim H, Han J, Park JH. 2020. Cyclodextrin polymer improves atherosclerosis therapy and reduces ototoxicity. J Control Release. 319:77–86.
   PubMed Web of Science ®Google Scholar
• Levental I, Levental KR, Heberle FA. 2020. Lipid rafts: controversies resolved, mysteries remain. Trends Cell Biol. 30(5):341–353.
   PubMed Web of Science ®Google Scholar
• Li Y, Xu QS, Wei P, Cheng LK, Peng Q, Li SG, Yin H, Du YG. 2014. Chitosan oligosaccharides downregulate the expression of E-selectin and ICAM-1 induced by LPS in endothelial cells by inhibiting MAP kinase signaling. Int J Mol Med. 33(2):392–400.
   PubMed Web of Science ®Google Scholar
• Li Z, Chen S, Gu Z, Chen J, Wu J. 2014. Alpha-cyclodextrin: enzymatic production and food applications. Trends Food Sci Tech. 35(2):151–160.
   Web of Science ®Google Scholar
• Li ZF, Wang M, Wang F, Gu ZB, Du GC, Wu J, Chen J. 2007. Gamma-cyclodextrin: a review on enzymatic production and applications. Appl Microbiol Biotechnol. 77(2):245–255.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Duchene D. 2007. Cyclodextrins and their pharmaceutical applications. Int J Pharm. 329(1–2):1–11.
   PubMed Web of Science ®Google Scholar
• Myers CL, Wertheimer SJ, Schembri-King J, Parks T, Wallace RW. 1992. Induction of ICAM-1 by TNF-alpha, IL-1-beta, and LPS in human endothelial-cells after down-regulation of PKC. Am J Physiol. 263(4):C767–C772.
   PubMedGoogle Scholar
• Ou HC, Lee WJ, Lee SD, Huang CY, Chiu TH, Tsai KL, Hsu WC, Sheu WHH. 2010. Ellagic acid protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway. Toxicol Appl Pharmacol. 248(2):134–143.
   PubMed Web of Science ®Google Scholar
• Ouweneel AB, Thomas MJ, Sorci-Thomas MG. 2020. The ins and outs of lipid rafts: functions in intracellular cholesterol homeostasis, microparticles, and cell membranes: thematic review series: biology of lipid rafts. J Lipid Res. 61(5):676–686.
   PubMed Web of Science ®Google Scholar
• Pilely K, Bakke SS, Palarasah Y, Skjoedt MO, Bartels ED, Espevik T, Garred P. 2019. alpha-Cyclodextrin inhibits cholesterol crystal-induced complement-mediated inflammation: a potential new compound for treatment of atherosclerosis. Atherosclerosis. 283:35–42.
   PubMed Web of Science ®Google Scholar
• Resni N, Repnik U, Kreft ME, Sepcic K, Macek P, Turk B, Veranic P. 2015. Highly selective anti-cancer activity of cholesterol-interacting agents methyl-β-cyclodextrin and ostreolysin A/pleurotolysin B protein complex on urothelial cancer cells. PLOS One. 10(9):e0137878.
   PubMed Web of Science ®Google Scholar
• Rios FJO, Ferracini M, Pecenin M, Koga MM, Wang YJ, Ketelhuth DFJ, Jancar S. 2013. Uptake of oxLDL and IL-10 production by macrophages requires PAFR and CD36 recruitment into the same lipid rafts. PLOS One. 8(10):e76893.
   PubMed Web of Science ®Google Scholar
• Sakurai T, Sakurai A, Chen Y, Vaisman BL, Amar MJ, Pryor M, Thacker SG, Zhang X, Wang X, Zhang Y, et al. 2017. Dietary alpha-cyclodextrin reduces atherosclerosis and modifies gut flora in apolipoprotein E-deficient mice. Mol Nutr Food Res. 61(8):1600804.
   Web of Science ®Google Scholar
• Sanlioglu S, Williams CM, Samavati L, Butler NS, Wang GS, McCray PB, Ritchie TC, Hunninghake GW, Zandi E, Engelhardt JF. 2001. Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B. J Biol Chem. 276(32):30188–30198.
   PubMed Web of Science ®Google Scholar
• Saokham P, Muankaew C, Jansook P, Loftsson T. 2018. Solubility of cyclodextrins and drug/cyclodextrin complexes. Molecules. 23(5):1161.
   PubMed Web of Science ®Google Scholar
• Takei A, Huang Y, Lopes-Virella MF. 2001. Expression of adhesion molecules by human endothelial cells exposed to oxidized low density lipoprotein. Influences of degree of oxidation and location of oxidized LDL. Atherosclerosis. 154(1):79–86.
   PubMed Web of Science ®Google Scholar
• Triantafilou M, Gamper FGJ, Lepper PM, Mouratis MA, Schumann C, Harokopakis E, Schifferle RE, Hajishengallis G, Triantafilou K. 2007. Lipopolysaccharides from atherosclerosis-associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2-induced inflammatory responses in human vascular endothelial cells. Cell Microbiol. 9(8):2030–2039.
   PubMed Web of Science ®Google Scholar
• Villacorta L, Chang L, Salvatore SR, Ichikawa T, Zhang J, Petrovic-Djergovic D, Jia L, Carlsen H, Schopfer FJ, Freeman BA, et al. 2013. Electrophilic nitro-fatty acids inhibit vascular inflammation by disrupting LPS-dependent TLR4 signalling in lipid rafts. Cardiovasc Res. 98(1):116–124.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang XW, Yu B, Peng XH, Liu Y, Wang AB, Zhao DZ, Pang DX, OuYang HS, Tang XC. 2019. Cyclodextrin ameliorates the progression of atherosclerosis via increasing high-density lipoprotein cholesterol plasma levels and anti-inflammatory effects in rabbits. J Cardiovasc Pharm. 73:334–342.
   PubMed Web of Science ®Google Scholar
• Zeng FF, Yang W, Huang J, Chen Y, Chen Y. 2013. Determination of the lowest concentrations of aldehyde fixatives for completely fixing various cellular structures by real-time imaging and quantification. Histochem Cell Biol. 139(5):735–749.
   PubMed Web of Science ®Google Scholar
• Zeng YC, Tao NB, Chung KN, Heuser JE, Lublin DM. 2003. Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1. J Biol Chem. 278(46):45931–45936.
   PubMed Web of Science ®Google Scholar
• Zhang WD, Xu Y, Chen G, Wang K, Shan WZ, Chen Y. 2019. Dynamic single-vesicle tracking of cell-bound membrane vesicles on resting, activated, and cytoskeleton-disrupted cells. Biochim Biophys Acta Biomembr. 1861(1):26–33.
   PubMed Web of Science ®Google Scholar
• Zhao WW, Wu CH, Chen XP. 2016. Cryptotanshinone inhibits oxidized LDL-induced adhesion molecule expression via ROS dependent NF-κB pathways. Cell Adh Migr. 10(3):248–258.
   PubMed Web of Science ®Google Scholar
• Zimmer S, Grebe A, Bakke SS, Bode N, Halvorsen B, Ulas T, Skjelland M, De Nardo D, Labzin LI, Kerksiek A, et al. 2016. Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming. Sci Transl Med. 8:333ra350.
   Web of Science ®Google Scholar